Migraines

A panel of experts that advises the US Food and Drug Administration (FDA) voted last week to reject the Agency’s proposal to make manufacturers of 11 epilepsy drugs put the strongest level of warning label on their products (the Black Box warning). The FDA had recommended the Black Box warning because studies showed the drugs had nearly double the risk of suicide compared to placebo, although in absolute terms it was still quite small.

More: continued here